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AmrZ is a major determinant of 
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The transcriptional regulator AmrZ is a global regulatory protein conserved within the pseudomonads. 
AmrZ can act both as a positive and a negative regulator of gene expression, controlling many 
genes implicated in environmental adaption. Regulated traits include motility, iron homeostasis, 
exopolysaccharides production and the ability to form biofilms. In Pseudomonas fluorescens F113, 
an amrZ mutant presents a pleiotropic phenotype, showing increased swimming motility, decreased 
biofilm formation and very limited ability for competitive colonization of rhizosphere, its natural 
habitat. It also shows different colony morphology and binding of the dye Congo Red. The amrZ 
mutant presents severely reduced levels of the messenger molecule cyclic-di-GMP (c-di-GMP), which 
is consistent with the motility and biofilm formation phenotypes. Most of the genes encoding proteins 
with diguanylate cyclase (DGCs) or phosphodiesterase (PDEs) domains, implicated in c-di-GMP turnover 
in this bacterium, appear to be regulated by AmrZ. Phenotypic analysis of eight mutants in genes 
shown to be directly regulated by AmrZ and encoding c-di-GMP related enzymes, showed that seven 
of them were altered in motility and/or biofilm formation. The results presented here show that in P. 
fluorescens, AmrZ determines c-di-GMP levels through the regulation of a complex network of genes 
encoding DGCs and PDEs.
AmrZ is a highly conserved transcriptional regulator within the pseudomonads1. It was originally identified as a 
transcriptional activator of alginate production in Pseudomonas aeruginosa and named AlgZ2. It was later shown 
to regulate also twitching motility and the name was changed to AmrZ (alginate and motility regulator)3. Its 
implication in regulation of motility was extended by the finding of AmrZ as a repressor of flagellar synthesis in 
cystic fibrosis mucoid isolates of P. aeruginosa. This repression is exerted through transcriptional repression of the 
master regulator of flagella synthesis fleQ4. Regulation of flagella synthesis by AmrZ through repression of fleQ 
was also observed in the plant-associated soil microbe P. fluorescens F1135. AmrZ acts therefore as an activator 
and a repressor of the transcription of different genes. ChIP-Seq analysis both in P. aeruginosa6 and P. fluorescens1 
has shown that AmrZ binds to hundreds of regions in both genomes and has been considered therefore to be 
a global regulator. Many of the AmrZ regulated genes are implicated in environmental adaption, and besides 
motility and alginate production, AmrZ regulates, among others, genes implicated in iron homeostasis, virulence, 
signal transduction and c-di-GMP production both in P. aeruginosa and P. fluorescens1,5,7. AmrZ has also been 
shown to transcriptionally repress cellulose production, which is c-di-GMP stimulated, in P. syringae8.
c-di-GMP is a messenger molecule implicated in bacterial adaption and defines bacterial life-styles. In this 
sense, the cytoplasmic levels of c-di-GMP are involved in the transition from sessile to planktonic life-style and, in 
the case of pathogens from acute to chronic infection9. c-di-GMP levels are maintained by the opposing activity 
of diguanylate cyclases and phosphodiesterases10. The former are proteins with GGDEF domains while the later 
are proteins containing EAL or HD-GYP domains11–13. GGDEF and EAL domains are often present in the same 
protein14. In these cases, proteins can either be bi-functional15 or only one of the domains possesses catalytic 
activity16. Other proteins implicated in c-di-GMP related functions contain sensor or receptor domains, such as 
the PilZ domain17, among others. We have previously shown by ChIP-Seq that in P. fluorescens F113, fourteen 
genes encoding proteins that contain GGDEF, EAL or HD-GYP domains are predicted to be targets of AmrZ1.
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The aim of this work was to investigate the role of AmrZ in the regulation of the cytoplasmic levels of 
c-di-GMP in P. fluorescens F113 and the impact on adaptive traits such as motility and biofilm formation. We 
have used a combination of RNA-Seq and the phenotypic analysis of mutants affected in AmrZ and in c-di-GMP 
related genes, confirmed to be regulated by this global transcriptional regulator.
Results
AmrZ affects motility, biofilm formation and competitive rhizosphere colonization. We have 
previously shown that AmrZ affects motility since an amrZ mutant is hypermotile due to enhanced production of 
flagellar components1,4. As shown in Fig. 1a, ectopic expression of a wild-type (wt) copy of the amrZ gene restores 
wild-type motility to the mutant strain. When grown in King’s B liquid medium under shaking conditions, the 
amrZ mutant does not form a pellicle on the tube surface compared to the pellicle produced by the wild-type 
strain F113 (Supplementary Fig. 1) suggesting a defect in biofilm formation. For this reason, we performed an 
assay to determine attachment to plastic microtiter plates. As shown in Fig. 1b, attachment to plastic in microti-
ter plates is severely reduced in the amrZ mutant when compared with the wt. Complementation of the mutant 
with a plasmid expressing amrZ from a constitutive promoter restored attachment to the wild-type levels. Taken 
together, these results show that AmrZ is required for formation of wild-type biofilm levels.
We have previously shown that hypermotile F113 mutants have increased ability for competitive rhizosphere 
colonization, even when they are defective for biofilm formation18. However, when rhizosphere colonization 
analyses were performed to compare the amrZ mutant with the wild-type strain (Fig. 1c), the amrZ mutant was 
severely impaired in rhizosphere competitive colonization, indicating that the function of AmrZ is required for 
fitness in the rhizosphere environment.
AmrZ regulates exopolysaccharide production and c-di-GMP levels. Motility and biofilm forma-
tion are inversely regulated by the messenger molecule c-di-GMP. This molecule also regulates exopolysaccha-
rides production. To test whether AmrZ affects exopolysaccharide production, the amrZ mutant and the wt strain 
were grown in King’s B medium in the presence of Congo Red, a dye that binds to several exopolysaccharides and 
has been used as an indirect measurement of c-di-GMP production. As shown in Fig. 2a, the two strains showed 
a different colouring pattern and colony morphology in the presence of Congo Red, indicating different exopol-
ysaccharide(s) production. To test the cytoplasmic concentration of c-di-GMP, two methods were used. First, 
introduction of the gfp based pCdrA biosensor19 in the wt strain and the amrZ mutant revealed that c-di-GMP 
concentration was higher in the wt strain (Fig. 2b). Quantification of fluorescence (Fig. 2c) confirmed that the 
wild-type strain contained about five times more c-di-GMP than the amrZ mutant. These results were validated 
by determination of c-di-GMP concentration in both strains through LC-MS (Fig. 2d), showing that c-di-GMP 
concentration in the wt was 6.4 pmol/mg protein compared to the 1.5 pmol/mg protein measured in the amrZ 
mutant. These results show that c-di-GMP concentration is 4.2 times higher in the wt, indicating that AmrZ is a 
major determinant of c-di-GMP levels in P. fluorescens F113.
AmrZ transcriptionally regulates a large number of genes implicated in c-di-GMP turno-
ver. We have previously shown that AmrZ binds to the promoter region of 14 genes implicated in c-di-GMP 
turnover1 (Table 1), which are therefore strong candidates to be directly regulated by AmrZ. We used an RNA-Seq 
approach to determine the influence of AmrZ in the expression of all the c-di-GMP turn-over related genes 
encoded in the F113 genome. Expression data showed the effects of AmrZ on the regulation of c-di-GMP genes. 
This regulation was especially evident during stationary phase, as shown in Fig. 3. During this phase, the expres-
sion of most of the c-di-GMP genes is affected by the lack of the amrZ gene. Out of the affected genes, five were 
shown to be repressed by AmrZ, since they showed higher expression in the amrZ mutant than in the wild-type 
strain. Conversely, twenty five c-di-GMP related genes were shown to be positively regulated by AmrZ, since 
their expression was lower in the amrZ mutant than in the wild-type. These results show that the expression of 
more than 65% of the c-di-GMP genes encoded in the F113 genome is affected by AmrZ, which acts mostly as 
a transcriptional activator for these genes. Furthermore, eight of the genes that were predicted as putative direct 
targets of AmrZ1, were indeed shown to be regulated by this protein (p < 0.003), seven of them positively and one 
of them negatively. Complete results for all the c-di-GMP genes (fold activation/repression, p and q values) are 
shown in Supplementary Table 1.
Most of the c-di-GMP related genes directly regulated by AmrZ are involved in motility and/
or biofilm formation. In order to determine roles for the AmrZ-regulated c-di-GMP genes in motility 
and biofilm formation, we constructed mutants in the eight c-di-GMP genes that were predicted to be AmrZ 
binding-targets by ChIP-Seq1 and also showed regulation by AmrZ by RNA-Seq. All the mutants were tested 
for swimming motility (Fig. 4a) and biofilm formation (Fig. 4b). Seven out of the eight mutants showed a motil-
ity and/or biofilm formation phenotype compared to wt F113. The mutant affected in the PsF113_ 4038 gene 
(gcbB), did not show any significant phenotype. Only three of the mutants, those affected in genes PsF113_0499 
(dipA), PsF113_0661 (gcbA) and PsF113_1982 (adrA) had a swimming motility phenotype, all of them showing 
increased motility. Six of the mutants had a significant biofilm formation phenotype: two of them increased bio-
film formation and four of them showed a significant reduction in biofilm formation. Two of the mutants affected 
in motility, dipA− and adrA− were also affected in biofilm formation, showing increased motility and reduced 
biofilm formation phenotypes. The swimming motility phenotypes of gcbA and adrA mutants and the biofilm for-
mation phenotype of the adrA mutant were complemented by expressing a wild-type copy of the respective gene 
under a constitutive promoter on a plasmid (Supplementary Fig. 2). However, we were unable to complement any 
of the phenotypes of the dipA mutant.
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Figure 1. AmrZ affects motility, biofilm formation and competitive rhizosphere colonization. (a) Swimming 
motility phenotypes of P. fluorescens F113, its amrZ mutant and complementation analysis of the mutant. 24 h 
haloes on SA with 0.3 agar were measured and referred to the control strains. Averages and standard deviation 
of three biological replicas with three technical replications are presented. (b) Biofilm formation (attachment) 
phenotypes of P. fluorescens F113, its amrZ mutant and complementation analysis of the mutant. Crystal violet 
staining the biomass attached to the walls of microtiter plates after 2 h of incubation was determined at OD590 
and referred to the control strains. Averages and standard deviations of three biological replicates with sixteen 
technical replications are presented. (c) Competitive rhizosphere colonization of P. fluorescens F113 and its 
amrZ mutant. Bacterial colonies recovered from the rhizosphere after one-week inoculation were tested for 
antibiotic resistance to distinguish the control and the tester strains and counted. Percentages of tester colonies 
referred to total colonies are represented in a logarithmic scale. Each experiment was repeated three times, 
with eight plants per experiment. Each dot represents results from a single plant. Asterisks represent statistical 
significance of the data: ***p < 0.001; ****p < 0.0001.
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Discussion
AmrZ has been shown to be a global regulator in Pseudomonas fluorescens1 and P. aeruginosa6. This global role 
leads to pleiotropic phenotypes of mutants lacking this regulator. As shown in Fig. 1, the F113 amrZ mutant 
is affected in motility and biofilm formation, being hypermotile and defective in biofilm formation. Although 
the hypermotility phenotype is also present in the P. aeruginosa mutant, the biofilm formation phenotypes are 
opposed: defective in P. fluorescens and enhanced in P. aeruginosa. The hyperbiofilm formation in the P. aerug-
inosa mutant was originally attributed to the overproduction of the psl exopolysaccharide20, not produced by 
F113, but was later related also to c-di-GMP levels6. An interesting phenotype of the F113 amrZ mutant is its 
compromised ability to competitively colonize the rhizosphere. F113 hypermotile mutants described earlier were 
hypercompetitive for rhizosphere colonization21, independently of their ability to form biofilms18. In turn, the 
rhizosphere colonization phenotype of the hypermotile amrZ mutant is similar to those mutants that have lost 
motility22 or chemotaxis23. These results indicate that factors besides motility and biofilm formation are affected 
in the amrZ mutant and that these factors are important for the fitness of P. fluorescens in the rhizosphere envi-
ronment. It is interesting to note that the P. aeruginosa amrZ mutant is less virulent than the wild-type strain in 
a murine system and that this lack of virulence is associated to reduced-lung colonization ability after intranasal 
Figure 2. AmrZ regulates exopolysaccharide production and c-di-GMP levels. (a) Morphology of colonies of 
P. fluorescens F113 and its amrZ mutant after 48 h growth in King’s B medium in the presence of Congo Red. 
(b) Streaks on LB medium of P. fluorescens F113 and its amrZ mutant harboring a plasmid with the gfp based 
pCdrA biosensor for c-di-GMP. Pictures were taken with a Leika binocular microscope, using a GFP filter set. 
Exposition time was 50 milliseconds. (c) Quantification of fluorescence emitted by P. fluorescens F113pCdrA 
and its amrZ mutant harboring pCdrA. Fluorescence of the amrZ mutant harboring pCdrA was referred to the 
fluorescence of the F113pCdrA strain. Averages and standard deviations of three independent experiments with 
sixteen technical replicas each are presented. (d) c-di-GMP quantification by LC-MS in P. fluorescens F113 and 
its amrZ mutant. Averages and standard deviation of five analyzed extracts per strain are presented. Asteriks 
represent statistical significance of the data: ****p < 0.0001.
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inoculation24. Considering the overlap of the AmrZ regulon in both strains1,6 it is likely that AmrZ plays a similar 
role in niche adaption in the rhizosphere and the lung.
Attachment and biofilm formation defects in pseudomonads are associated to defects in exopolysaccharides 
production and low levels of c-di-GMP. The F113 amrZ mutant forms reduced amounts of biofilm when grown 
in glass tubes and shows reduced attachment to plastic in microtiter plate assays. In order to test for differences in 
exopolysaccharides production, a Congo Red binding-assay was used. Congo Red binds to different extracellular 
components including several polysaccharides such as cellulose and to amyloid proteins25,26. The results presented 
here, show a different colony morphology and coloring pattern for the wild-type strain and the amrZ mutant, 
indicating alterations in cellular envelopes. However, since the F113 genome does not encode genes for cellulose, 
pel or psl synthesis, the exopolysaccharides produced by P. aeruginosa and implicated in biofilm formation, the 
differences observed in F113 should be due to differences in the production of other polysaccharides or other 
extracellular components. Regarding c-di-GMP levels, the results presented here show that the F113 mutant 
has severely reduced levels of cytoplasmic c-di-GMP, as revealed by two independent methods: a fluorescent 
biosensor and direct measurements by LC-MS. These findings fit well with the paradigmatic role of c-di-GMP 
in determining bacterial life-style, since low levels of c-di-GMP are related to high motility and reduced biofilm 
formation, supporting a planktonic rather than sessile life-style9. However, the phenotypes of c-di-GMP levels in 
the F113 amrZ mutant and the P. aeruginosa mutant are opposed, since the P. aeruginosa amrZ mutant contains 
more than two fold more c-di-GMP than the wild-type6. In the case of P. aeruginosa, these c-di-GMP levels are 
in concordance with the hyperbiofilm formation phenotype of the amrZ mutant. On the contrary, the high levels 
of c-di-GMP do not explain the hypermotility phenotype of the mutant. This apparent contradiction might be 
explained by the direct transcriptional repression of motility genes by AmrZ, observed both in P. aeruginosa6 and 
P. fluorescens F11327,28.
AmrZ is therefore a major determinant of c-di-GMP levels in P. fluorescens and P. aeruginosa. We have shown 
here that in F113, AmrZ influences the transcription of a majority of the genes encoding enzymes implicated in 
c-di-GMP turnover. Regulation of c-di-GMP related genes by AmrZ in this strain is mostly transcriptional acti-
vation, although five genes, two of them encoding GGDEF proteins and the other three GGDEF-EAL proteins, 
seem to be repressed by AmrZ. Among the twenty five genes transcriptionally activated by AmrZ, thirteen encode 
GGDEF, eight GGDEF-EAL, three EAL and one HD-GYP proteins. These results show that in F113, c-di-GMP 
levels are controlled by AmrZ in a complex regulatory network and that the low levels of c-di-GMP observed in 
the amrZ mutant are the result of a balance between activation and repression of a large number of genes encod-
ing DGCs and PDEs. These findings contrast with those in P. aeruginosa where most of the high c-di-GMP level 
was attributed to the repression of a single gene encoding a DGC6. Regarding the fourteen c-di-GMP related 
genes previously identified as putative targets of AmrZ by ChIP-Seq1, RNA-Seq has confirmed the regulation 
by AmrZ of eight of them. Six of them showed expression levels that were more than two fold higher than in the 
wild-type strain indicating that activation was the general trend. Conversely, only one (dipA) was shown to be 
repressed by AmrZ. For three of the genes identified by ChIP-Seq but not appearing as regulated in the RNA-Seq 
experiment, very low expression, around the limit of detection was observed under the experimental conditions 
tested.
Phenotypic analysis of the eight mutants affected in genes confirmed to be directly regulated by AmrZ, has 
implicated most of them in biofilm formation, while only three were affected in motility. Two out of these three 
were affected both in motility and biofilm formation. These results are very similar to those observed in a sys-
tematic analysis of the phenotypes of 30 putative DGCs encoded in the P. fluorescens Pf-01 genome29, indicating 
that different c-di-GMP pools, generated and degraded by different enzymes, impact on different pathways for 
motility and biofilm formation. It is interesting to note that one of these genes did not show any significant role in 
motility or biofilm formation, at least under our experimental conditions, suggesting that it might be implicated 
in the regulation of other traits.
Locus Name or homologue c-di-GMP relates domains Reference
PSF113_0499 dipA (PA5017) GGDEF & EAL 30
PSF113_0661 gcbA (Pfl01_0623) GGDEF 29
PSF113_0715 yfiN (PA1120) GGDEF 48
PSF113_1982 adrA (PFL_4532) GGDEF 49
PSF113_2333 mucR (PA1727) GGDEF 50
PSF113_3553 PA4108 HD-GYP —
PSF113_4023 PFL_1902 GGDEF & EAL 49
PSF113_4038 gcbB (Pfl01_1790) GGDEF 29
PSF113_4360 Pfl01_1678 GGDEF & EAL 29
PSF113_4681 Pfl01_4551 GGDEF & EAL 29
PSF113_4776 gcbC (Pfl01_4666) GGDEF 29
PSF113_4827 — GGDEF —
PSF113_5064 morA (PA4601) GGDEF & EAL 51
PSF113_5392 PFL_5686 GGDEF 49
Table 1. c-di-GMP related genes identified as putative AmrZ binding targets.
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Figure 3. AmrZ transcriptionally regulates a large number of genes implicated in c-di-GMP turnover. Heatmap 
showing the differential expression of all the P. fluorescens F113 genes encoding enzymes involved in c-di-GMP 
turnover, in the wild-type strain and the amrZ mutant, in stationary phase. The heatmap was constructed based 
on FPKM values obtained by RNA-Seq data. The four different colors of the gene legends, depend on the protein 
domains: blue, GGDEF; orange, EAL; green, GGDEF and EAL; red, HD-GYP. The color scale represents the log 
base 2 of fold change of each gene relative to the wild-type: green, genes repressed by AmrZ, red-orange, genes 
upregulated by AmrZ; yellow, no AmrZ regulation. Log2 fold change values and p and q values for each gene 
are provided in Supplementary Table 1. *AmrZ binding site in gene promoter; **AmrZ binding site in gene 
promoter and expression modified in amrZ mutant (p-value < 0.003).
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We have also found a correlation between motility and biofilm phenotypes and the domains present in the 
encoded proteins: All of the predicted DGCs (increasing motility and/or decreasing biofilm formation in the 
mutants), contained a GGDEF motif. Similar results were found with respect to PDEs, since all contained an 
EAL or HD-GYP motif. On the other hand, phenotypic typing of PsF113_0499, indicates that this gene encodes 
a DGC. However, this gene is an orthologue of dipA, a gene that has been shown to encode a PDE in P. aerugi-
nosa30 and possesses a highly degenerated GGDEF motif, unlikely to be catalytic. It is important to remark that 
we were unable to complement either the biofilm or the motility phenotypes of this mutant with a wild-type copy 
of the gene, indicating an indirect or gene-copy dependent regulation of these traits by this gene. In P. aeruginosa 
two c-di-GMP related genes have also been shown as targets of AmrZ6. One of these genes, encoding the DGC 
AdcA (also named GcbA) is an orthologue of the AmrZ regulated PsF113_0661. However, while this gene is 
AmrZ-repressed in P. aeruginosa, it is AmrZ-activated in F113. It is interesting to note that not only genes encod-
ing c-di-GMP enzymes, but also genes encoding sensors or receptors for this molecule such as the PilZ protein 
FlgZ28 and its P. aeruginosa orthologue are also predicted targets of AmrZ, both in P. fluorescens1 and in P. aerug-
inosa6, suggesting that c-di-GMP sensing is also implicated in AmrZ regulation.
Conclusions
AmrZ is a global regulator required for niche adaption in Pseudomonas fluorescens and P. aeruginosa. An impor-
tant part of AmrZ activity is to modulate the intracellular levels of c-di-GMP, which in turn regulates swimming 
motility and biofilm formation, among other adaptive traits. While in P. aeruginosa AmrZ contributes to a low-
ering in c-di-GMP levels, in P. fluorescens AmrZ increases the levels of the messenger molecule. Taken together, 
the results presented here show that although AmrZ is a major determinant of c-di-GMP levels by regulating 
the expression of genes encoding DGCs and PDEs in P. fluorescens F113 and P. aeruginosa PAO1, regulation is 
very different in both strains. While in PAO1 only one gene encoding a DGC and one encoding a PDE are tran-
scriptionally repressed, in F113 c-di-GMP levels are the consequence of activation and repression of a complex 
network of genes encoding many of the DGCs and PDEs present in the bacterium.
Figure 4. Most of the c-di-GMP related genes that are directly regulated by AmrZ are involved in motility and/
or biofilm formation. (a) Relative swimming motility phenotype of P. fluorescens F113 and its eight mutants 
affected in the indicated gene (ORF number in www.pseudomonas.com)47. Experiments and replicas were 
performed as in Fig. 1. (b) Relative biofilm formation (attachment) phenotype of the same strains above. 
Experiments and replicas were performed as in Fig. 1. Asterisks represent statistical significance of the data: 
****p < 0.0001.
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Materials and Methods
Bacterial strains, plasmids and mutant construction. Pseudomonas fluorescens F113 and derivatives 
were routinely grown in SA31 medium at 28 °C. Purified agar (1.5%) was used for solid medium and antibiotics 
were used for selection as required (rifampicin (Rif), 100 µg/mL; tetracycline (Tet), 70 µg/mL; kanamycin (Km), 
50 µg/mL; cicloheximide (Clh), 10 µg/mL, gentamicin (Gm), 3 µg/mL and piperacillin (Pip) 30 µg/mL). To induce 
expression of vector promoters, IPTG 0.25 mM was used. E. coli DH5α was used for DNA manipulation and was 
grown at 37 °C in LB medium supplemented with bacteriological agar (1.5%) and/or antibiotics when required 
(ampicillin (Amp), 100 µg/mL; tetracycline (Tet), 10 µg/mL; kanamycin (Km), 25 µg/mL; gentamicin (Gm), 10 µg/
mL; piperacillin (Pip) 30 µg/mL and chloramphenicol 30 µg/mL).
Mutants were constructed by homologous recombination of internal fragments of the targeted gene, cloned 
into the suicide vectors pK18mobsacB32 or pG18mob233. The constructs were introduced into F113 by triparental 
mating and selected for homologous recombination. Mutant construction is detailed in Supplementary Table 1. 
All mutants were checked by PCR and Southern blotting. Complementation of mutants was performed by 
expressing a wild-type copy of the gene in expression vectors pVLT3134 or pBBRMCS535 (Supplementary Table 1).
Phenotypic analysis of mutants. Swimming motility was determined in SA plates supplemented with 
0.3% of purified agar as described before36. Swimming halo diameters were determined after 24 h incubation at 
28 °C. Experiments were performed in triplicate, with three replicas in each experiment.
To examine biofilm formation a modified version of a previously described quantification method of Peeters 
et al. was used37. Briefly, overnight cultures grown in LB medium were adjusted to OD600 at 0.8 into a fresh LB and 
incubated at 28 °C for 2 h in 96-well-microlitre plates. After staining and washing, absorbance of the eluted crys-
tal violet was measured at OD590 on a Synergy HT multi-mode microplate reader (BioTek, Wilusky, VT, USA). 
Experiments were repeated three times with 16 technical replicas in each assay.
Competitive rhizosphere colonization analysis was performed essentially as described in38 using alfalfa 
(Medicago sativa var. Resis) seedlings. P. fluorescens Kmr was used as a control22. Control and tester strains were 
co-inoculated at 1 × 103 colony-forming units (CFUs) to one-week-old seedlings. After a further week, rhizos-
phere bacteria were recovered by vortexing and dilutions plated on SA agar with Rif and Clh. CFU of each strain 
were distinguished and counted by growth with and without antibiotic. Experiments were performed in triplicate 
and each experiment contained eight independent plants.
Congo Red binding and colony morphology was determined on King’s B plates39 supplemented with 0.004% Congo 
Red. 10 µL drops of an overnight culture were spotted on plates and incubated at 28 °C for 48 h before inspection.
c-di-GMP determinations. Fluorescence intensity emitted by F113 and amrZ− strains harbouring the 
pCdrA::gfpC biosensor vector19 was visualized with a Leica M165 FC stereomicroscope using a GFP filter set 
(Excitation/Emission 494/518 nm) with different exposure times. Pictures were taken with the Leica Application 
Suite software, with exposure time elapsed to 50 milliseconds.
Indirect quantitative detection of c-di-GMP intracellular concentration was measured by microplate-based 
assays of the wt and amrZ− strains harbouring pCdrA::gfpC vector. Overnight cultures grown in LB were diluted 
to OD600 at 0.5 and fluorescence (excited at 485/20, emission at 528/20 nm) was measured in a Synergy HT 
multi-mode microplate reader (BioTek, Wilusky, VT, USA) using 96 black-well plates. The experiments were 
conducted in triplicate with 16 technical replicas in each experiment.
Extraction and quantification of c-di-GMP was performed as described in40. Extraction was performed from 
50 mL of LB cultures grown to OD600 of 0.6. Pellets were used for protein determination by A280 in a NanoDrop 
spectrophotometer, after solubilization in 200 µL of 0.1 M NaOH and heating at 95 °C for 15 min. Nucleotide 
extracts were subjected to LC-MS as described40 and c-di-GMP was quantified by using an external standard 
calibration curve. Five extracts were analyzed for each strain.
Statistical analysis. For all the tested phenotypes, results were statistically analyzed using GraphPad Prism 
version 7.00 (GraphPad software, La Jolla, California, USA). Data were compared using one way analysis of 
variance (ANOVA) followed by Tukey´s correction of multiple comparison test (p ≤ 0.0001) or unpaired t test 
two-tailed (p ≤ 0.0001).
RNA extraction and RNA-Seq analysis. RNA was extracted from cultures grown in SA medium to expo-
nential (OD600 0.6) and stationary phase (OD600 1.2). Three independent cultures per strain and condition were 
mixed prior to RNA extraction. RNA isolation was performed using TRIzolTM (Invitrogen)-chloroform followed 
by an isopropanol precipitation. The obtained RNA was treated with DNase (RQ1, Promega) and finally was puri-
fied using the RNAclean and ConcentratorTM-5 column (Zymo Research). rRNA depletion, library construction 
and sequencing was custom performed by Sistemas Genómicos (Paterna, Valencia). Two libraries per sample 
were prepared and sequencing was carried out using Illumina MiSeq paired end, 2 × 100 bp.
Illumina reads were clipped and trimmed to remove low quality nucleotides as well as putative Illumina adapters 
by using Trimmomatic v 0.3541, specifying a sliding window of 4 nts with an average phred quality of 20 and 50 nts 
as minimum read length to be conserved. Filtered paired reads were aligned to reference genome P. fluorescens F113 
(GenBank: NC_016830) with Bowtie v242. Alignment SAM files were sorted and converted to BAM using SAMtools43 
and gene counts were determined by HTSeq44. HTSeq-count tables were used to calculate expression levels for each 
gene using FPKM formula45 and statistical significance using DESeq 2 R package46. Relative expression values were 
calculated as follows log2 (FPKMAmrZ) − log2(FPKMF113). P. fluorescens F113 genes annotated as encoding diguanylate 
cyclases and phosphodiesterases were selected to prepare the heatmap expression figure with pheatmap R package.
Data availability. RNA-Seq raw data have been deposited at NCBI as Bioproject PRJNA419480.
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